Financials
- Market Capitalization 396.11 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-6.02
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3076 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | -4.49% | +0.25% | +1.00% | +36.03% | 400.55 M USD | ||
| 3079 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.86 USD | -2.61% | -0.41% | +10.96% | +1.89% | 398.74 M USD | ||
| 3090 | CTNM Contineum Therapeutics, Inc. - Common stock | 17.05 USD | -1.16% | +0.29% | +8.25% | +11.66% | 393.84 M USD | ||
| 3107 | EYPT EyePoint, Inc. - Common Stock | 4.48 USD | -3.24% | -13.35% | -65.03% | -62.67% | 386.23 M USD |